The Oncology Institute, Inc. (NASDAQ:TOI) Sees Significant Increase in Short Interest

The Oncology Institute, Inc. (NASDAQ:TOI) was the recipient of a large increase in short interest during the month of February. As of February 15th, there was short interest totalling 934,800 shares, an increase of 188.3% from the January 31st total of 324,300 shares. Based on an average daily volume of 1,970,000 shares, the days-to-cover ratio is currently 0.5 days. Approximately 2.5% of the shares of the company are sold short.

Oncology Institute Stock Performance

Shares of TOI stock traded down $0.04 during trading hours on Friday, reaching $0.85. 301,543 shares of the company’s stock were exchanged, compared to its average volume of 870,819. Oncology Institute has a fifty-two week low of $0.13 and a fifty-two week high of $2.10. The stock has a market capitalization of $64.38 million, a P/E ratio of -1.09 and a beta of 0.37. The business has a fifty day moving average price of $0.65 and a 200-day moving average price of $0.41. The company has a quick ratio of 2.27, a current ratio of 2.49 and a debt-to-equity ratio of 5.91.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the business. Renaissance Technologies LLC raised its stake in shares of Oncology Institute by 7.1% in the fourth quarter. Renaissance Technologies LLC now owns 182,000 shares of the company’s stock valued at $56,000 after purchasing an additional 12,000 shares in the last quarter. HighTower Advisors LLC raised its stake in shares of Oncology Institute by 190.8% in the third quarter. HighTower Advisors LLC now owns 81,362 shares of the company’s stock valued at $27,000 after purchasing an additional 53,382 shares in the last quarter. Jane Street Group LLC raised its stake in shares of Oncology Institute by 613.6% in the fourth quarter. Jane Street Group LLC now owns 127,659 shares of the company’s stock valued at $39,000 after purchasing an additional 109,769 shares in the last quarter. Virtu Financial LLC acquired a new position in shares of Oncology Institute in the fourth quarter valued at $41,000. Finally, Tiff Advisory Services LLC raised its stake in shares of Oncology Institute by 13.2% in the fourth quarter. Tiff Advisory Services LLC now owns 2,979,141 shares of the company’s stock valued at $921,000 after purchasing an additional 346,256 shares in the last quarter. 36.86% of the stock is currently owned by institutional investors and hedge funds.

Oncology Institute Company Profile

The Oncology Institute, Inc, an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services.